---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-24-003008"
form_type: "8-K"
ticker: "MCAG"
cik: "0001859035"
company_name: "Mountain Crest Acquisition Corp. V"
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T00:54:19.955506+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Mountain Crest V announces non-binding term sheet to combine with CUBEBIO at $620M pre-money value

## Summary
- Pre-transaction equity value of CUBEBIO set at $620 million, subject to adjustment.
- CUBEBIO is a Korea-based cancer diagnostics company using urine-based technology.
- Non-binding term sheet dated April 26, 2024; definitive merger agreement yet to be signed.
- Mountain Crest V is a SPAC; has completed four prior business combinations.
- Global Fund LLC engaged as advisor to CUBEBIO.

## SEC filing metadata
- accession: 0001829126-24-003008
- form_type: 8-K
- ticker: MCAG
- cik: 0001859035
- company_name: Mountain Crest Acquisition Corp. V
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859035/000182912624003008/0001829126-24-003008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859035/000182912624003008/mountaincre5_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-24-003008
- JSON: https://secwatch.observer/filing/0001829126-24-003008.json
- Plain text: https://secwatch.observer/filing/0001829126-24-003008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.